CAS 603288-22-8: LY2090314
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LY2090314 REF: IN-DA00ECDZCAS: 603288-22-8 | 99% | To inquire | Thu 27 Mar 25 |
 | LY2090314 REF: TM-T1755CAS: 603288-22-8 | 99.03% - 99.88% | 48.00 €~638.00 € | Thu 03 Apr 25 |
 | LY 2090314 REF: TR-L395020CAS: 603288-22-8 | - - - | 34,767.00 € | Wed 07 May 25 |
 | LY 2090314 REF: 3D-FL104294CAS: 603288-22-8 | Min. 95% | 331.00 €~896.00 € | Thu 08 May 25 |
Ref: IN-DA00ECDZ
| 5mg | 103.00 € | ||
| 10mg | 138.00 € | ||
| 25mg | 195.00 € | ||
| 50mg | 327.00 € | ||
| 100mg | 524.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Thursday 27 Mar 2025
LY2090314
CAS:603288-22-8
LY2090314, a potent GSK-3α/β blocker (IC50: 1.5/0.9 nM), could boost platinum chemo. Tested in leukemia …
Formula:
C28H25FN6O3
Purity:
99.03% - 99.88%
Color and Shape:
Solid
Molecular weight:
512.53
- Inhibitors
- Stem Cell and Derivatives
- Stem Cells
- PI3K/Akt/mTOR Signaling
- See more categories
- gsk-3
Ref: TM-T1755
| 1mg | 48.00 € | ||
| 2mg | 63.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 153.00 € | ||
| 25mg | 264.00 € | ||
| 50mg | 432.00 € | ||
| 100mg | 638.00 € | ||
| 1mL*10mM (DMSO) | 107.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
LY 2090314
Controlled ProductCAS:603288-22-8
Formula:
C28H25FN6O3
Color and Shape:
Neat
Molecular weight:
512.5
Ref: TR-L395020
| 25mg | 34,767.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025
LY 2090314
CAS:603288-22-8
Inhibitor of GSK3 kinase
Formula:
C28H25FN6O3
Purity:
Min. 95%
Molecular weight:
512.54 g/mol
Ref: 3D-FL104294
| 10mg | 331.00 € | ||
| 50mg | 896.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
